Computational Drug Discovery Solution
Tokyo-1
(Providing computing resources and pre-competitive community)
“Tokyo-1” aims to build an innovation hub that will lead digital transformation in the healthcare industry in Japan.
“Tokyo-1” offers a comprehensive range of computing resources, AI solutions and communities.
For details, please refer to Tokyo-1 website.
Tarck record
Since our establishment in Nov 2021, we have worked with more than 8 Japanese pharmaceutical/biotech companies.
Target Analysis
Ultra-Large Scale Virtual Screening（SBVS & LBVS）
Absolute Binding Free-Energy Perturbation（ABFEP）
ADME Prediction Model building
Active Learning platform building
Selection and design for epitopes of antibody-directed peptide vaccines
Collaborative research
Providing computing resources (GPUs) and pre-competitive community (Tokyo-1 project)
